Julian Blagg
VP Drug Discovery

DPhil, FRSC

Dr Blagg has over 30 years’ experience in medicinal chemistry and drug discovery; he was most recently Deputy Director and Head of Chemistry at The CRUK Cancer Therapeutics Unit at the Institute of Cancer Research (ICR), London, UK where he focused on the discovery of small molecule therapeutics for the treatment of cancer and became a strong advocate for the use of quality chemical probes in biomedical research. Dr Blagg joined the ICR in 2007 following 19 years in the pharmaceutical industry at Pfizer in the US and the UK, where he was responsible for the progression of multiple development candidates into clinical trials across four therapeutic areas.